Electromedical Technologies, Inc.
EMED · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $2 |
| Enterprise Value | $2 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 8.9% | -50.8% | -19.1% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -104.1% | -102.1% | -15.8% | -24.2% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -4,617.2% | -1,280.7% | -1,660.6% | 604.1% |
| Net Income | -$1 | -$0 | -$0 | $0 |
| % Margin | -8,340.1% | -1,507.2% | -2,010.7% | 210.3% |
| EPS Diluted | 0 | 0 | -0 | 0.001 |
| % Growth | – | 100% | -125% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |